Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The SURMOUNT 5 study published in the New England Journal of Medicine showed that at week 72, the average weight loss ratio of the Tirzepatide treatment group reached 20.2%, with an average weight loss of 22.8kg, significantly better than that of a single GLP-1 receptor agonist
However, Tirzepatides dual-receptor action gives it a slight advantage in supporting better metabolic control
People with obesity tend to have lower levels of GLP-1, Dr
Safety signals issued by regulatory agencies prompt further investigation but do not definitively establish causality or confirm that Ozempic causes cancer in humans
Mounjaro Approved by the FDA for Type 2 Diabetes , Mounjaro helps lower blood sugar levels while supporting weight loss as a secondary benefit
The formula needed to be free of synthetic surfactants
